PATENT CLAIM ANALYSIS

Application Number: 16087947
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["546", "053000"]

Abstract:
The present invention provides a medicament useful for treatment and/or prevention of cancer, a vaccine adjuvant, and an inhibitor of immune checkpoint comprising a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein Bonds a-d, Ring A, R 1 , R 1′ , R 2 , R 2′ , R 3 -R 8 , and n are as defined in the present specification.

Claim (Index 15):
The medicament of  claim 14 , wherein the cancer is malignant melanoma, glioblastoma, lung cancer, gastric cancer, colorectal cancer, liver cancer, pancreatic cancer, renal cancer, adrenal cancer, biliary tract cancer, esophageal cancer, pharyngeal cancer, laryngeal cancer, oral cancer, bladder cancer, tongue cancer, thyroid cancer, skin cancer, breast cancer, prostate cancer, testicular cancer, uterine cancer, cervical cancer, ovarian cancer, osteosarcoma, chondrosarcoma, rhabdomyosarcoma, leiomyosarcoma, leukemia comprising adult T-cell leukemia, malignant lymphoma, or multiple myeloma.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 97.0
- Lexical Diversity: 1.37037
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15766985', '14238507', '10932463', '11587906', '15799771']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7532523824894403
- 35 USC 102 Novelty (BERT): 0.5212042418832935
- Combined Prediction Score: 0.7300475684288257
- Mean Citation Score: 319.059382
- Max Citation Score: 326.9722
- Similarity Product: 263.84802522161004

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test